BTMD Q1 2026 Earnings EPS Beats Estimates by 2371 Amid Revenue Discrepancy Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending BRFH Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Progress Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings WiderthanExpected Loss Highlights DevelopmentStage Challenges Novagold Resources Inc NG Q1 2026 Earnings EPS Exceeds Estimates as Company Maintains Focus on Donlin Gold Project GPCR Q1 2026 Earnings Smaller Loss Than Expected as Pipeline Advances